We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

164 hedge funds and large institutions have $454M invested in Viking Therapeutics in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more call options, than puts

Call options by funds: $29.3M | Put options by funds: $18M

31% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 45

26% more capital invested

Capital invested by funds: $360M → $454M (+$94.8M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.27% less ownership

Funds ownership: 65.79% → 63.51% (-2.3%)

2% less funds holding

Funds holding: 168 → 164 (-4)

13% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 30

Holders
164
Holders Change
-4
Holders Change %
-2.38%
% of All Funds
3.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
59
Reduced
45
Closed
30
Calls
$29.3M
Puts
$18M
Net Calls
+$11.3M
Net Calls Change
+$9.45M

Top Buyers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
+$6.78M
2
ACH
ArrowMark Colorado Holdings
Colorado
+$5.87M
3
SSA
Schonfeld Strategic Advisors
New York
+$5.48M
4
Bank of America
Bank of America
North Carolina
+$5.42M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.36M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.6M
2
Citigroup
Citigroup
New York
-$7.4M
3
SFM
Sphera Funds Management
Israel
-$5.71M
4
PM
Prosight Management
Texas
-$4.77M
5
Two Sigma Investments
Two Sigma Investments
New York
-$2.98M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
76
Prelude Capital Management
New York
$556K +$208K +24,872 +80%
WC
77
Woodstock Corp
Massachusetts
$544K +$458K +54,763 New
Squarepoint
78
Squarepoint
New York
$503K -$212K -25,343 -33%
HP
79
Hikari Power
Japan
$497K +$83.7K +10,000 +25%
MA
80
MYDA Advisors
New York
$497K +$293K +35,000 +233%
Royal Bank of Canada
81
Royal Bank of Canada
Ontario, Canada
$483K +$109K +12,994 +37%
OPPM
82
Opus Point Partners Management
New York
$482K +$406K +48,485 New
UBS AM
83
UBS AM
Illinois
$470K +$171K +20,459 +76%
WAM
84
Wealthspire Advisors (Maryland)
Maryland
$450K -$41.9K -5,000 -10%
Manulife (Manufacturers Life Insurance)
85
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$406K +$44K +5,254 +15%
Creative Planning
86
Creative Planning
Kansas
$389K +$54.4K +6,500 +20%
AIG
87
American International Group
New York
$387K -$4.4K -526 -1%
CS
88
Credit Suisse
Switzerland
$378K +$64.1K +7,660 +25%
Envestnet Asset Management
89
Envestnet Asset Management
Illinois
$370K +$127K +15,125 +68%
RJFSA
90
Raymond James Financial Services Advisors
Florida
$345K +$104K +12,453 +56%
SI
91
Stephens Inc
Arkansas
$334K -$97.2K -11,610 -26%
AQR Capital Management
92
AQR Capital Management
Connecticut
$327K -$10.5K -1,256 -4%
JG
93
Jefferies Group
New York
$313K -$193K -23,002 -42%
BC
94
Brinker Capital
Pennsylvania
$311K +$77.3K +9,230 +42%
CM
95
Caption Management
Oklahoma
$299K +$251K +30,000 New
VEA
96
Virtus ETF Advisers
New York
$287K -$28.9K -3,457 -11%
MIM
97
MetLife Investment Management
New Jersey
$284K – – –
IGGA
98
Iron Gate Global Advisors
Utah
$257K – – –
AGM
99
Alpine Global Management
New York
$249K – – –
VOYA Investment Management
100
VOYA Investment Management
Georgia
$249K – – –
2 3
4
5 6

VKTX Hedge Fund Activity: Q1 2019 in Review

164 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q1 2019, worth a combined $454M — up 26% from $360M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of VKTX and 26 opened new positions — a net loss of 4 holders — while 45 trimmed existing stakes and 59 added.

The largest buyer was Rubric Capital Management (New York), opening a new position worth an estimated $6.78M. The largest seller was Fidelity Investments, cutting an estimated $16.6M.

  • 164 institutional investors held Viking Therapeutics (VKTX) as of Q1 2019, down from 168 in Q4 2018.
  • Funds reported $454M of Viking Therapeutics stock for Q1 2019, up 26% quarter-over-quarter.
  • 26 funds opened new Viking Therapeutics positions in Q1 2019 and 30 closed out, a net change of -4 holders.
  • The largest Viking Therapeutics buyer in Q1 2019 was Rubric Capital Management (New York), an estimated $6.78M added.
  • The largest Viking Therapeutics seller in Q1 2019 was Fidelity Investments, an estimated $16.6M sold.

Based on aggregated 13F filings for Q1 2019.